logo

For the Inventor, By the Inventor

Palo Alto, CA, United States of America

Riboscience LLC


USPTO Granted Patents = 12

% Expired Patents = 16.7



Forward Citations = 18

Loading Chart...
Loading Chart...

6 inventors (with patents filed for the assignee):

goldMedal Klaus G Klumpp (10 out of 12 patents)

silverMedal Mark Smith (10 out of 51 patents)

bronzeMedal Zhuming Zhang (2 out of 29 patents)

4.  Jing Zhang (2 out of 15 patents)

5.  Francisco Xavier Talamas (1 out of 32 patents)

6.  Ronald Hawley (1 out of 1 patent)

7.  David Bernard Smith (89 patents)

8.  Klaus Klumpp (1 patent)

9.  Jing Zhang (0 patent)

10.  Joseph Armstrong Martin (0 patent)

11.  Christopher Mcguigan (0 patent)


12 patents:

1. 12029744 - Bicyclic heteroaryl derivatives as ectonucleotide pyrophosphatase phosphodiesterase 1 inhibitors (2024-07-09),
2. 11351186 - 4'-fluoro-2′-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replication (2022-06-07),
3. 10953030 - 4'-fluoro-2′-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replication (2021-03-23),
4. 10682369 - 4'-fluoro-2′-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replication (2020-06-16),
5. 10358458 - 4'-vinyl substituted nucleoside derivatives as inhibitors of respiratory syncytial virus RNA replication (2019-07-23),
6. 10092649 - 4'-difluoromethyl substituted nucleoside derivatives as inhibitors of influenza RNA replication (2018-10-09),
7. 9895442 - 4'-fluoro-2′-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replication (2018-02-20),
8. 9708357 - 4'-azido, 3′-fluoro substituted nucleoside derivatives as inhibitors of HCV RNA replication (2017-07-18),
9. 9694028 - 4'-azido, 3′-deoxy-3′-fluoro substituted nucleoside derivatives as inhibitors of HCV RNA replication (2017-07-04),
10. 9370569 - 4'-difluoromethyl substituted nucleoside derivatives as inhibitors of influenza RNA replication (2016-06-21),
11. 9249176 - 4'-azido, 3′-deoxy-3′-fluoro substituted nucleoside derivatives as inhibitors of HCV RNA replication (2016-02-02),
12. 9108999 - 2', 4′-difluoro-2′-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replication (2015-08-18),
RIBOSCIENCE LLC is a leading biotechnology company specializing in the development and manufacturing of RNA-based therapeutics and diagnostics. With a dedicated team of scientists and state-of-the-art facilities, we strive to deliver innovative solutions that address unmet medical needs. Our focused research areas include RNA interference (RNAi), mRNA technology, and microRNA applications. Through collaborative partnerships and cutting-edge research, RIBOSCIENCE is committed to revolutionizing the field of RNA biology and making a positive impact on healthcare.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

12 Patents

#146 in Palo Alto, CA

#6,047 in California

#25,496 in US

#48,036 in the World

Palo Alto, CA (US)
Palo Alto, CA, United States of America

Riboscience LLC

Forward Citations = 18

6 inventors:

goldMedal Klaus G Klumpp (10 out of 12 patents)

silverMedal Mark Smith (10 out of 51 patents)

bronzeMedal Zhuming Zhang (2 out of 29 patents)

4.  Jing Zhang (2 out of 15 patents)

5.  Francisco Xavier Talamas (1 out of 32 patents)

Please report any incorrect information to [email protected]
Loading…